• Under Armour recently reported fourth-quarter 2026 results showing sales of US$1,171.16 million, a narrower net loss of US$43.39 million, and a full-year net loss of US$495.64 million on lower annual sales of US$4,966.37 million.
• Alongside cautious guidance for a slight revenue decline in fiscal 2027, Under Armour entered an early-stage research collaboration with Persona AI to test its performance materials on humanoid robots working in high-risk industrial environments, extending its performance focus beyond human athletes.
• We’ll now examine how Under Armour’s deeper full-year loss and cautious revenue outlook influence its pre-existing investment narrative around brand elevation.

The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Under Armour Investment Narrative Recap

To own Under Armour today, you need to believe the brand-first, premiumization strategy can eventually translate a smaller, more focused business into consistent profitability. The latest results, with a deeper full-year net loss of US$495.64 million and guidance for slightly lower FY 2027 revenue, keep the near term shaped by execution risk, particularly around margins and demand in North America. This news materially reinforces that the biggest short term catalyst and risk both sit in how effectively management improves the quality of sales.

The Persona AI collaboration is the most intriguing recent announcement in this context. While early stage and not financially material near term, it reinforces Under Armour’s identity around performance materials and innovation, which is central to its brand elevation narrative. For investors focused on catalysts, this kind of R&D partnership may matter less for immediate earnings and more for whether Under Armour can rebuild distinct brand relevance versus larger competitors over time.

Yet, while the headline story is about brand and innovation, investors should be aware that pressure on North American demand and margins could still…

Under Armour’s narrative projects $5.5 billion revenue and $224.5 million earnings by 2029. This requires 3.2% yearly revenue growth and a $744.2 million earnings increase from -$519.7 million today.

Uncover how Under Armour's forecasts yield a $7.73 fair value, a 41% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already cautious, assuming roughly flat revenue near US$5.1 billion and earnings around US$131 million by 2028, and when you compare that to concerns about North American dependence you can see how their more pessimistic view may or may not be reinforced by these latest results, which is why it is worth weighing how your own expectations line up with both the consensus and the bearish case.

Explore 7 other fair value estimates on Under Armour - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Under Armour research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Under Armour research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Under Armour's overall financial health at a glance.

Ready For A Different Approach?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Outshine the giants: these 13 early-stage AI stocks could fund your retirement.
• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 46 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.